T. Rowe Price Investment Management, Inc.

Source: SEC Form 13F · as of Mar 2026

T. Rowe Price Investment Management, Inc. holds 43 biotech & pharma companies tracked by BioSniper, totaling $4.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

43

Total value held

$4.0M

CompanySharesValue
LLYELI LILLY & Co1,026,556$944K
UNHUnitedHealth Group Incorporated Common Stock (DE)3,455,149$935K
ABTABBOTT LABORATORIES2,764,429$284K
ACLXArcellx, Inc.2,255,878$259K
BIIBBIOGEN INC.1,160,989$213K
RGENREPLIGEN CORP1,366,680$161K
NUVLNuvalent, Inc.1,413,637$145K
SHCSotera Health Company9,125,621$131K
DNTHDianthus Therapeutics, Inc. /DE/1,292,182$108K
MOHMolina Healthcare Inc556,690$74K
CRNXCrinetics Pharmaceuticals, Inc.1,940,622$70K
GHGuardant Health Inc.755,707$70K
RVMDREVOLUTION MEDICINES, INC.664,047$65K
TECHBIO-TECHNE Corp1,150,339$60K
PRAXPraxis Precision Medicines, Inc.175,237$56K
XENEXenon Pharmaceuticals Inc.951,955$55K
AGIOAGIOS PHARMACEUTICALS, INC.1,488,740$50K
RIOTRiot Platforms, Inc.3,837,108$47K
PMPhilip Morris International Inc216,236$36K
GILDGILEAD SCIENCES, INC.230,625$32K
KODKodiak Sciences Inc.836,944$32K
ALKSAlkermes plc.894,276$32K
SRPTSarepta Therapeutics, Inc.1,133,308$25K
RAPPRapport Therapeutics, Inc.620,600$19K
PRGOPERRIGO Co plc1,622,832$17K
TVTXTravere Therapeutics, Inc.520,604$15K
ADPTAdaptive Biotechnologies Corp919,278$13K
TNGXTango Therapeutics, Inc.440,015$9K
STOKStoke Therapeutics, Inc.250,913$8K
CNTACentessa Pharmaceuticals plc170,016$7K
JNJJOHNSON & JOHNSON16,925$4K
GEHCGE HealthCare Technologies Inc.56,883$4K
MCKMcKesson Corporation4,221$4K
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.1,000,000$3K
CAHCardinal Health Inc.11,377$2K
AXSMAxsome Therapeutics, Inc.13,643$2K
ABBVAbbVie Inc.5,805$1K
BMYBRISTOL MYERS SQUIBB CO19,177$1K
PFEPFIZER INC35,847$1K
MRKMerck & Co., Inc.8,270$995
IQVIQVIA Holdings Inc.2,965$506
APLSApellis Pharmaceuticals, Inc.5,162$208
REGNREGENERON PHARMACEUTICALS, INC.267$207

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    T. Rowe Price Investment Management, Inc. — Biotech 13F Holdings & Portfolio | BioSniper